Literature DB >> 12800510

Occurrence of extended-spectrum beta-lactamases among Escherichia coli isolates from hospitalized and healthy children.

R Franiczek1, B Sobieszczańska, M Grabowski, K Mowszet, T Pytrus.   

Abstract

The prevalence of extended-spectrum beta-lactamases (ESBL) was determined among isolates of Escherichia coli (n = 63) isolated from hospitalized (43) and healthy (20) children. Ten isolates (21%) were ESBL-positive for two screening tests, the double disk-synergy test and the Oxoid Combination Disk method. One ESBL-positive isolate came from a healthy child. The transfer frequency of oxyimino-beta-lactam resistance from ESBL-producing isolates to E. coli K12 C600 recipient strain ranged from 10(-8) to 10(-5) per donor cell. Donor strains and transconjugants displayed susceptibility patterns typical of ESBL producers. They were resistant to oxyimino-beta-lactams but susceptible to clavulanic acid and carbapenems. Seven out of the 10 ESBL-positive isolates were found to produce MR/MS fimbria, which may play an important role in the colonization of the human intestinal mucosa.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12800510     DOI： 10.1007/bf02930963

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  20 in total

1.  Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains.

Authors:  Haluk Vahaboglu; Figen Coskunkan; Ozlem Tansel; Recep Ozturk; Nursu Sahin; Iftahar Koksal; Bekir Kocazeybek; Muserref Tatman-Otkun; Hakan Leblebicioglu; Mehmet Ali Ozinel; Halis Akalin; Sesin Kocagoz; Volkan Korten
Journal:  J Med Microbiol       Date:  2001-07       Impact factor: 2.472

Review 2.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 3.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

4.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

5.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

Authors:  D M Livermore; M Yuan
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

6.  Occurrence and genetic association of selected virulence factors in clinical Escherichia coli isolates.

Authors:  E Bogyiová; L Siegfried; M Kmetová; Z Sándorcínová; A Liptáková; E Biros
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

Review 7.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

8.  Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems.

Authors:  V Majtán; L Majtánová
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

9.  Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics.

Authors:  M T Tejedor-Junco; M González-Martín; P Lupiola; Z González-Lama
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

10.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553
View more
  7 in total

1.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.

Authors:  Sofia Ny; Roman Kozlov; Uga Dumpis; Petra Edquist; Kirsi Gröndahl-Yli-Hannuksela; Anna-Maria Kling; Danuta O Lis; Christoph Lübbert; Monika Pomorska-Wesołowska; Ivan Palagin; Aija Vilde; Jaana Vuopio; Jan Walter; Karin Tegmark Wisell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-18       Impact factor: 3.267

3.  Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich.

Authors:  S Benczeová; D Adam; M Vrábelová; D Michálková-Papajová; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 4.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Proteolytic activity in Serratia marcescens clinical isolates.

Authors:  R Coria-Jiménez; C Zárate-Aquino; O Ponce-Ponce
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  Curli expression of enterotoxigenic Escherichia coli.

Authors:  E Szabó; A Skedsmo; A Sonnevend; K Al-Dhaheri; L Emody; A Usmani; T Pál
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

7.  Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections.

Authors:  R Franiczek; B Krzyzanowska; I Dolna; G Mokracka; K Szufnarowski
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.